Trial Profile
Phase II study of XELOX as adjuvant chemotherapy for locally advanced rectal cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 17 Jul 2012
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Oxaliplatin (Primary)
- Indications Rectal cancer
- Focus Therapeutic Use
- Acronyms CORONAII
- 17 Jul 2012 New trial record